Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.250
+0.220 (10.84%)
At close: May 22, 2025, 4:00 PM
2.201
-0.049 (-2.17%)
After-hours: May 22, 2025, 7:46 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Nuvation Bio stock ranges from a low of $5.00 to a high of $10. The average analyst price target of $8.20 forecasts a 264.44% increase in the stock price over the next year.
Price Target: $8.20 (+264.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +122.22% | May 16, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $6 | Buy | Initiates | $6 | +166.67% | Apr 23, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +344.44% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +344.44% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +388.89% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
15.37M
from 7.87M
Increased by 95.27%
Revenue Next Year
68.48M
from 15.37M
Increased by 345.44%
EPS This Year
-0.67
from -2.11
EPS Next Year
-0.68
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.4M | 122.1M | 270.7M | ||
| Avg | 15.4M | 68.5M | 159.0M | ||
| Low | 8.4M | 24.5M | 49.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 171.4% | 694.3% | 295.2% | ||
| Avg | 95.3% | 345.4% | 132.2% | ||
| Low | 7.0% | 59.4% | -28.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.59 | -0.54 | -0.43 | ||
| Avg | -0.67 | -0.68 | -0.57 | ||
| Low | -0.72 | -0.87 | -0.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.